{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:30:36Z","timestamp":1783071036794,"version":"3.54.6"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cll.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T07:43:44Z","timestamp":1457768624000},"page":"331-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction"],"prefix":"10.1016","volume":"36","author":[{"given":"Alejandro","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methodius G.","family":"Tuuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony O.","family":"Odibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.cll.2016.01.007_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199904223401603","article-title":"Birth weight in relation to morbidity and mortality among newborn infants","volume":"340","author":"McIntire","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"Kaufmann","year":"2003","journal-title":"Biol Reprod"},{"issue":"9249","key":"10.1016\/j.cll.2016.01.007_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"issue":"Suppl A","key":"10.1016\/j.cll.2016.01.007_bib4","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/plac.1999.0522","article-title":"Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia","volume":"21","author":"Caniggia","year":"2000","journal-title":"Placenta"},{"issue":"Pt 14","key":"10.1016\/j.cll.2016.01.007_bib5","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1113\/jphysiol.2009.173252","article-title":"Intrauterine growth restriction, human placental development and trophoblast cell death","volume":"587","author":"Scifres","year":"2009","journal-title":"J\u00a0Physiol"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9378(93)90151-8","article-title":"Elevated circulating thrombomodulin in severe preeclampsia","volume":"169","author":"Hsu","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.282.4.356","article-title":"Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study","volume":"282","author":"Mills","year":"1999","journal-title":"JAMA"},{"issue":"4 Pt 1","key":"10.1016\/j.cll.2016.01.007_bib10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0002-9378(91)90435-T","article-title":"High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone","volume":"165","author":"Taylor","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-0528.2004.00071.x","article-title":"Is pre-eclampsia more than one disease?","volume":"111","author":"Vatten","year":"2004","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.2006.00882.x","article-title":"Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction","volume":"113","author":"Egbor","year":"2006","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/uog.5400","article-title":"First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia","volume":"32","author":"Melchiorre","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.cll.2016.01.007_bib16","series-title":"The lancet handbook of essential concepts in clinical research","year":"2006"},{"issue":"9","key":"10.1016\/j.cll.2016.01.007_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cll.2016.01.007_bib18","series-title":"How to report statistics in medicine","author":"Lang","year":"1997"},{"key":"10.1016\/j.cll.2016.01.007_bib19","series-title":"Chesley's hypertensive disorders in pregnancy","year":"2009"},{"key":"10.1016\/j.cll.2016.01.007_bib20","series-title":"Studying a study and testing a test","year":"1987"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2016.01.007_bib21","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ijgo.2004.03.009","article-title":"Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia","volume":"85","author":"Villar","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00006254-200406000-00025","article-title":"Prediction of preeclampsia: can it be achieved?","volume":"59","author":"Farag","year":"2004","journal-title":"Obstet Gynecol Surv"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","article-title":"World Health Organization systematic review of screening tests for preeclampsia","volume":"104","author":"Conde-Agudelo","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.3881","article-title":"Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14\u00a0weeks' gestation","volume":"29","author":"Pilalis","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib25","doi-asserted-by":"crossref","first-page":"330.e1","DOI":"10.1016\/j.ajog.2007.09.031","article-title":"Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images","volume":"198","author":"Toal","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1503\/cmaj.1080039","article-title":"Use of Doppler ultrasonography to predict pre-eclampsia","volume":"179","author":"Conde-Agudelo","year":"2008","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1469-0705.1998.12010045.x","article-title":"Imaging of placental vasculature using three-dimensional ultrasound and color power Doppler: a preliminary study","volume":"12","author":"Pretorius","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9391","key":"10.1016\/j.cll.2016.01.007_bib29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(03)14514-X","article-title":"3-dimensional colour power angiography for staging human placental development","volume":"362","author":"Konje","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/uog.2641","article-title":"Comparison between three-dimensional placental volume at 12\u00a0weeks and uterine artery impedance\/notching at 22\u00a0weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population","volume":"27","author":"Hafner","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib31","doi-asserted-by":"crossref","first-page":"415.e1","DOI":"10.1016\/j.ajog.2008.10.041","article-title":"Effects of maternal cigarette smoking on placental volume and vascularization measured by 3-dimensional power Doppler ultrasonography at 11+0 to 13+6\u00a0weeks of gestation","volume":"200","author":"Rizzo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1515\/JPM.2002.004","article-title":"The assessment of placental blood vessels by three-dimensional power Doppler ultrasound","volume":"30","author":"Matijevic","year":"2002","journal-title":"J\u00a0Perinat Med"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1515\/JPM.2004.043","article-title":"Reproducibility of the study of placental vascularization by three-dimensional power Doppler","volume":"32","author":"Merce","year":"2004","journal-title":"J\u00a0Perinat Med"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.placenta.2009.12.018","article-title":"Validation of placental vascular sonobiopsy for obtaining representative placental vascular indices by three-dimensional power Doppler ultrasonography","volume":"31","author":"Tuuli","year":"2010","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib35","first-page":"765","article-title":"Assessment of placental vascularization by three-dimensional power Doppler \u201cvascular biopsy\u201d in normal pregnancies","volume":"46","author":"Merce","year":"2005","journal-title":"Croat Med J"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.placenta.2009.02.010","article-title":"Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses","volume":"30","author":"Noguchi","year":"2009","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/uog.5212","article-title":"Is three-dimensional power Doppler ultrasound useful in the assessment of placental perfusion in normal and growth-restricted pregnancies?","volume":"31","author":"Guiot","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/uog.5394","article-title":"Methodological considerations for the correct application of quantitative three-dimensional power Doppler angiography","volume":"32","author":"Raine-Fenning","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/uog.6110","article-title":"Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment","volume":"32","author":"Raine-Fenning","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/uog.6138","article-title":"Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: an in-vitro flow phantom experiment","volume":"32","author":"Raine-Fenning","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/uog.6112","article-title":"Evaluation of volume vascularization index and flow index: a phantom study","volume":"32","author":"Schulten-Wijman","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8\u20139","key":"10.1016\/j.cll.2016.01.007_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.placenta.2004.03.002","article-title":"Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries","volume":"25","author":"Viero","year":"2004","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib43","doi-asserted-by":"crossref","first-page":"363.e1","DOI":"10.1016\/j.ajog.2006.10.897","article-title":"Usefulness of a placental profile in high-risk pregnancies","volume":"196","author":"Toal","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006254-199005000-00001","article-title":"Evaluation of elevations in maternal serum alpha-fetoprotein: a review","volume":"45","author":"Thomas","year":"1990","journal-title":"Obstet Gynecol Surv"},{"issue":"12","key":"10.1016\/j.cll.2016.01.007_bib46","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.placenta.2008.09.004","article-title":"Screening for placental insufficiency in high-risk pregnancies: is earlier better?","volume":"29","author":"Costa","year":"2008","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib47","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2353\/ajpath.2007.061035","volume":"170","author":"Cindrova-Davies","year":"2007","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9440(10)63192-6","article-title":"Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in\u00a0vitro: a potential mediator of the inflammatory response in preeclampsia","volume":"164","author":"Hung","year":"2004","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2353\/ajpath.2006.060161","article-title":"Trophoblastic oxidative stress and the release of cell-free feto-placental DNA","volume":"169","author":"Tjoa","year":"2006","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.cll.2016.01.007_bib50","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJM199008163230710","article-title":"Platelets and the beginnings of preeclampsia","volume":"323","author":"Redman","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2016.01.007_bib51","first-page":"709","article-title":"Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia","volume":"108","author":"Bosio","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.cll.2016.01.007_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2393-8-33","article-title":"Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis","volume":"8","author":"Morris","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbrc.2003.12.183","article-title":"ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase","volume":"314","author":"Ito","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib54","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1083\/jcb.149.5.1143","article-title":"The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading","volume":"149","author":"Iba","year":"2000","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.AOG.0000165829.65319.65","article-title":"Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia","volume":"106","author":"Laigaard","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pd.1957","article-title":"ADAM12s in maternal serum as a potential marker of pre-eclampsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/pd.1665","article-title":"First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system","volume":"27","author":"Cowans","year":"2007","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib58","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/AOG.0b013e318188d6f9","article-title":"First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome","volume":"112","author":"Poon","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A\u00a0novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib60","doi-asserted-by":"crossref","first-page":"35.e1","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/1933719108328615","article-title":"PP13 mRNA expression in trophoblasts from preeclamptic placentas","volume":"16","author":"Sekizawa","year":"2009","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pd.1921","article-title":"First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes","volume":"28","author":"Cowans","year":"2008","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib63","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.cll.2016.01.007_bib64","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-0528.2008.01902.x","article-title":"Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study","volume":"115","author":"Gonen","year":"2008","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","article-title":"Longitudinal determination of serum placental protein 13 during development of preeclampsia","volume":"24","author":"Huppertz","year":"2008","journal-title":"Fetal Diagn Ther"},{"issue":"9","key":"10.1016\/j.cll.2016.01.007_bib66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.placenta.2012.05.012","article-title":"First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review","volume":"33","author":"Schneuer","year":"2012","journal-title":"Placenta"},{"issue":"12","key":"10.1016\/j.cll.2016.01.007_bib67","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11-13\u00a0weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cll.2016.01.007_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.59.110106.214058","article-title":"Preeclampsia and angiogenic imbalance","volume":"59","author":"Maynard","year":"2008","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajog.2004.11.038","article-title":"Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia","volume":"193","author":"Powers","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"15","key":"10.1016\/j.cll.2016.01.007_bib71","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria","volume":"278","author":"Sugimoto","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.5184","article-title":"Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction","volume":"31","author":"Crispi","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib74","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10641950701825937","article-title":"Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension","volume":"27","author":"Teixeira","year":"2008","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib76","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.0000187899.34379.b0","article-title":"Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia","volume":"46","author":"Lam","year":"2005","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib77","doi-asserted-by":"crossref","first-page":"244.e1","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib78","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11\u00a0+ 0 to 13\u00a0+ 6\u00a0weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.cll.2016.01.007_bib79","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A\u00a0prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib80","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-0528.2008.02074.x","article-title":"First trimester urinary placental growth factor and development of pre-eclampsia","volume":"116","author":"Savvidou","year":"2009","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.cll.2016.01.007_bib82","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/pd.2065","article-title":"Circulating soluble endoglin and placental abruption","volume":"28","author":"Signore","year":"2008","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib83","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.ajog.2008.06.069","article-title":"First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia","volume":"199","author":"Baumann","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"14","key":"10.1016\/j.cll.2016.01.007_bib84","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1016\/S0021-9258(17)47274-7","article-title":"A\u00a0platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets","volume":"259","author":"Hsu-Lin","year":"1984","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0092-8674(89)90292-4","article-title":"PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes","volume":"59","author":"Larsen","year":"1989","journal-title":"Cell"},{"issue":"1 Pt 1","key":"10.1016\/j.cll.2016.01.007_bib86","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0002-9378(96)70407-6","article-title":"Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances","volume":"174","author":"Halim","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.cll.2016.01.007_bib87","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/pd.1821","article-title":"Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15\u00a0weeks' gestation","volume":"27","author":"Banzola","year":"2007","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/10641950500281068","article-title":"First trimester sex hormone-binding globulin and subsequent development of preeclampsia or other adverse pregnancy outcomes","volume":"24","author":"Spencer","year":"2005","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib89","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a009816","article-title":"Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia","volume":"149","author":"Williams","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0301-2115(01)00484-5","article-title":"Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia","volume":"100","author":"Serin","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14767050500246466","article-title":"TNF-receptor levels in preeclampsia\u2013results of a longitudinal study in high-risk women","volume":"18","author":"Schipper","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/uog.6275","article-title":"First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia","volume":"33","author":"Leal","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib93","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jcem.87.4.8405","article-title":"First trimester insulin resistance and subsequent preeclampsia: a prospective study","volume":"87","author":"Wolf","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.cll.2016.01.007_bib94","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1471-0528.2006.01078.x","article-title":"Adiponectin and insulin resistance in early- and late-onset pre-eclampsia","volume":"113","author":"D'Anna","year":"2006","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib95","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1086\/316888","article-title":"A\u00a0genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2","volume":"67","author":"Moses","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib96","first-page":"1158","article-title":"A\u00a0genomewide linkage study of preeclampsia\/eclampsia reveals evidence for a candidate region on 4q","volume":"60","author":"Harrison","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.cll.2016.01.007_bib97","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pd.2109","article-title":"Gene expression in chorionic villous samples at 11\u00a0weeks' gestation from women destined to develop preeclampsia","volume":"28","author":"Farina","year":"2008","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.placenta.2008.09.015","article-title":"Altered global gene expression in first trimester placentas of women destined to develop preeclampsia","volume":"30","author":"Founds","year":"2009","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib99","doi-asserted-by":"crossref","first-page":"98.e1","DOI":"10.1016\/j.ajog.2008.07.063","article-title":"Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction","volume":"200","author":"Alberry","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/pd.596","article-title":"Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction\u2013a pilot study","volume":"23","author":"Caramelli","year":"2003","journal-title":"Prenat Diagn"},{"issue":"5 Pt 1","key":"10.1016\/j.cll.2016.01.007_bib101","first-page":"669","article-title":"Disturbed feto-maternal cell traffic in preeclampsia","volume":"91","author":"Holzgreve","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","article-title":"Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia","volume":"45","author":"Lo","year":"1999","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib103","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9440(10)65123-1","article-title":"Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall","volume":"155","author":"DiFederico","year":"1999","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib104","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajog.2004.01.040","article-title":"Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia","volume":"191","author":"Cotter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pd.1645","article-title":"Free fetal DNA is not increased before 20\u00a0weeks in intrauterine growth restriction or pre-eclampsia","volume":"27","author":"Crowley","year":"2007","journal-title":"Prenat Diagn"},{"issue":"7145","key":"10.1016\/j.cll.2016.01.007_bib106","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/447655a","article-title":"Replicating genotype-phenotype associations","volume":"447","author":"NCI-NHGRI Working Group on Replication in Association Studies","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib108","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/uog.5402","article-title":"Uterine artery Doppler at 11\u00a0+ 0 to 13\u00a0+ 6\u00a0weeks and 21\u00a0+ 0 to 24\u00a0+ 6\u00a0weeks in the prediction of pre-eclampsia","volume":"32","author":"Plasencia","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9461","key":"10.1016\/j.cll.2016.01.007_bib109","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib110","doi-asserted-by":"crossref","first-page":"326.e1","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib111","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib112","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/uog.7439","article-title":"Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13\u00a0weeks","volume":"34","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/uog.14928","article-title":"Biophysical and biochemical markers at 30-34\u00a0weeks' gestation in the prediction of adverse perinatal outcome","volume":"47","author":"Valino","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.007_bib114","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/uog.15663","article-title":"Biophysical and biochemical markers at 35-37\u00a0weeks' gestation in the prediction of adverse perinatal outcome","volume":"47","author":"Valino","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cll.2016.01.007_bib115","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.cll.2016.01.007_bib116","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/14767058.2012.755167","article-title":"Maternal serum activin-A at 30-33\u00a0weeks in the prediction of preeclampsia","volume":"26","author":"Lai","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib117","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0897.1997.tb00222.x","article-title":"Placental cytokines and the pathogenesis of preeclampsia","volume":"37","author":"Conrad","year":"1997","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.cll.2016.01.007_bib118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1471-0528.1995.tb09020.x","article-title":"Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia","volume":"102","author":"Vince","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.cll.2016.01.007_bib119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/14767058.2012.755168","article-title":"Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33\u00a0weeks in the prediction of preeclampsia","volume":"26","author":"Mosimann","year":"2013","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.cll.2016.01.007_bib120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pd.4129","article-title":"Maternal serum cytokines at 30-33\u00a0weeks in the prediction of preeclampsia","volume":"33","author":"Mosimann","year":"2013","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.cll.2016.01.007_bib121","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/uog.14861","article-title":"Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34\u00a0weeks","volume":"46","author":"Bakalis","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8326 Pt 1","key":"10.1016\/j.cll.2016.01.007_bib122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(83)91970-0","article-title":"New Doppler technique for assessing uteroplacental blood flow","volume":"1","author":"Campbell","year":"1983","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib123","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J\u00a0Perinat Med"},{"issue":"12","key":"10.1016\/j.cll.2016.01.007_bib124","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.7863\/ultra.32.12.2107","article-title":"Third-trimester abnormal uterine artery Doppler findings are associated with adverse pregnancy outcomes","volume":"32","author":"Shwarzman","year":"2013","journal-title":"J\u00a0Ultrasound Med"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/uog.14777","article-title":"Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 30-34\u00a0weeks","volume":"45","author":"Bakalis","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.007_bib126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000343665","article-title":"Uterine artery Doppler at 30-33\u00a0weeks' gestation in the prediction of preeclampsia","volume":"33","author":"Lai","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"10.1016\/j.cll.2016.01.007_bib127","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/uog.14847","article-title":"Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37\u00a0weeks","volume":"45","author":"Fadigas","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.cll.2016.01.007_bib128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/uog.13246","article-title":"Angiogenic factors vs Doppler surveillance in the prediction of adverse outcome among late-pregnancy small-for-gestational-age fetuses","volume":"43","author":"Lobmaier","year":"2014","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271216300075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T01:21:29Z","timestamp":1655256089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271216300075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0272271216300075"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.007","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}